Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Issue 20 (2nd September 2020)

• Record Type: Journal Article
• Authors: Ren, Zhigang; Fan, Yajuan; Li, Ang; Shen, Quanquan; Wu, Jian; Ren, Lingyan; Lu, Haifeng; Ding, Suying; Ren, Hongyan; Liu, Chao; Liu, Wenli; Gao, Dan; Wu, Zhongwen; Guo, Shiyuan; Wu, Ge; Liu, Zhangsuo; Yu, Zujiang; Li, Lanjuan
• Is Part Of: Advanced science. Volume 7:Issue 20(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-09-02
• Subjects: chronic kidney disease -- gut microbiome -- microbial markers -- non‐invasive diagnostic tools; Science -- Periodicals; 505
• DOI: 10.1002/advs.202001936
• Languages: English
• ISSNs: 2198-3844

Abstract

Abstract: Gut microbiota make up the largest microecosystem in the human body and are closely related to chronic metabolic diseases. Herein, 520 fecal samples are collected from different regions of China, the gut microbiome in chronic kidney disease (CKD) is characterized, and CKD classifiers based on microbial markers are constructed. Compared with healthy controls (HC, n = 210), gut microbial diversity is significantly decreased in CKD ( n = 110), and the microbial community is remarkably distinguished from HC. Genera Klebsiella and Enterobacteriaceae are enriched, while Blautia and Roseburia are reduced in CKD. Fifty predicted microbial functions including tryptophan and phenylalanine metabolisms increase, while 36 functions including arginine and proline metabolisms decrease in CKD. Notably, five optimal microbial markers are identified using the random forest model. The area under the curve (AUC) reaches 0.9887 in the discovery cohort and 0.9512 in the validation cohort (49 CKD vs 63 HC). Importantly, the AUC reaches 0.8986 in the extra diagnosis cohort from Hangzhou. Moreover, Thalassospira and Akkermansia are increased with CKD progression. Thirteen operational taxonomy units are correlated with six clinical indicators of CKD. In conclusion, this study comprehensively characterizes gut microbiome in non‐dialysis CKD and demonstrates the potential of microbial markers as non‐invasive diagnostic tools for CKD in different regions of China. Abstract : Compared with healthy controls, gut microbial diversity in CKD is significantly reduced, Klebsiella and Akkermansia are significantly increased, Roseburia and Faecalibacterium are significantly reduced, and the predictive function of gut microbiota such as ascorbate metabolism and lipopolysaccharide biosynthesis is significantly enhanced. Akkermansia increases along with the progression of CKD, which is positively correlated with serum creatinine and blood urea nitrogen, and negatively correlated with estimated glomerular filtration rate, and could be used as a therapeutic target to improve the prognosis of CKD. Importantly, gut microbial markers have strong diagnostic potential for CKD and achieve cross‐regional validation, which can be used as a non‐invasive diagnostic tool for CKD.